Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Efficacy and Safety of LAS41003 in the Treatment of Inflammatory Tinea Pedis

This study has been completed.
Information provided by (Responsible Party):
Almirall, S.A. Identifier:
First received: March 30, 2010
Last updated: July 5, 2012
Last verified: November 2010
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2010
  Primary Completion Date: June 2010 (Final data collection date for primary outcome measure)